Chronic treatment with CP-55,940 regulates corticotropin releasing factor and proopiomelanocortin gene expression in the hypothalamus and pituitary gland of the rat

Life Sciences

Volumn 64, Issue 11, 1999, Pages 905-911

  Corchero, Javier ^a,b   Fuentes, José A ^a   Manzanares, Jorge ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b INSTITUTO PLURIDISCIPLINAR   (Spain)

Author keywords

Arcuate nucleus; Cannabinoids; Corticotropin releasing factor; CP 55,940; mRNA; Paraventricular nucleus; Pituitary; Proopiomelanocortin

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; CANNABINOID; CANNABINOID RECEPTOR AGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR; PROOPIOMELANOCORTIN;

ARCUATE NUCLEUS; ARTICLE; CORTICOTROPIN RELEASE; HISTOCHEMISTRY; HORMONAL REGULATION; HYPOPHYSIS INTERMEDIATE LOBE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IN SITU HYBRIDIZATION; MALE; METABOLIC ACTIVATION; MOLECULAR INTERACTION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INTERACTION; RAT; REGULATORY MECHANISM; THALAMUS MIDLINE NUCLEUS;

ANIMALS; CANNABINOIDS; CORTICOTROPIN-RELEASING HORMONE; CYCLOHEXANOLS; GENE EXPRESSION REGULATION; HYPOTHALAMUS; MALE; PITUITARY GLAND; PRO-OPIOMELANOCORTIN; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0033524969     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(99)00016-8     Document Type: Article

References (22)

1. W.L. Dewey, Pharmacol. Rev. 38 151-178 (1986).
2. F. Rodriguez De Fonseca, P. Rubio, F. Menzaghi, E. Merlo-Pich, J. Rivier, G.F. Koob and M. Navarro, J. Pharmacol. Exp. Ther. 276 56-64 (1996).
3. P. Rubio, F. Rodriguez De Fonseca, R.M. Munoz, C. Ariznavarreta, J.L. Martin-Calderon and M. Navarro, Life Sci. 56 2169-2176 (1995).
4. J. Weidenfeld, S. Feldman and R. Mechoulam, Neuroendocrinology. 59 110-112 (1994).
5. L.S. Melvin, G.M. Milne, M.R. Johnson, B. Submaniam, G.H. Wilken, A.C. Howlett, Mol. Pharmacol. 44 1008-15 (1993).
6. W.S.III Young, T.I. Bonner and M.R. Barnn, Proc. Natl. Acad. Sci. USA. 83 9827-9831 (1986).
7. F. Rodriguez De Fonseca, M.R.A. Carrera, M. Navarro, G.F. Koob and F. Weiss, Science. 276 2050-2054 (1997).
8. S.L. Lightman and W.S.III Young, J. Physiol. 403 511-523 (1988).
9. C. Rivier, T. Imaki and W. Vale, Brain Res. 520 1-5 (1990).
10. C. Rivier and S. Lee, Mol. Cell. Neurosci. 5 189-195 (1994).
11. J. Corchero, J.A. Fuentes and J. Manzanares, Eur. J. Pharmacol. 323 193-195 (1997).
12. B.A. Eipper and R.E. Mains, Endocr. Rev. 1 1-27 (1980).
13. R.B. Emerson and B.A. Eipper, J. Neurosci. 6 837-849 (1986).
14. C. Gramsch, G. Kleber, V. Höllt, A. Pasi, P. Mehracin, A. Herz, Brain Res. 192 109-119 (1980).
15. P.E. Sawchenko, L. Swanson and S.A. Joseph, Brain Res. 232 365-374 (1982).
16. Z. Liposits, L. Sievers, W.K. Paull, Histochemistry. 88 227-234 (1988).
17. K.E. Nikolarakis, O.F.X. Almeida and A. Herz, Brain Res. 399 152-155 (1986).
18. J.P. Loeffler, B.A. Demeneix, N.A. Kley and V. Höllt, Neuroendocrinology. 47 95-101 (1988).
19. M. Navarro, J.J. Fernandez-Ruiz, R. De Miguel, M.L. Hernandez, M. Cebeira, and J.A. Ramos, Pharmacol. Biochem. Behav. 45 291-298 (1993).
20. F. Rodriguez De Fonseca, J.J. Fernandez-Ruiz, L.L. Murphy, M. Cebeira, R.W. Steger, A. Bartke and J.A. Ramos, Pharmacol. Biochem. Behav. 42 269-275 (1992).
21. J. Romero, E. Garcia-Palomero, S.Y. Lin, J.A. Ramos, A. Makriyannis and J.J. Fernandez-Ruiz, Life Sci. 58 1249-1257 (1996).
22. V. Höllt and I. Haarman, Biochem. Biophys. Res. Commun. 124 407-415 (1984).